CrkL meditates CCL20/CCR6-induced EMT in gastric cancer

Gang Han1, Dawei Wu2, Yongan Yang2

  • 1Department of General Surgery, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan, Shandong, China.

Cytokine
|June 6, 2015
PubMed
Abstract

Insights

Crk-like adapter protein (CrkL) drives gastric cancer progression by mediating CCL20/CCR6-induced epithelial-mesenchymal transition (EMT) through the Akt pathway. Targeting this CCL20/CCR6-CrkL-EMT axis offers a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Crk-like adapter protein (CrkL) is a key regulator of epithelial-to-mesenchymal transition (EMT).
  • The precise mechanisms of CC chemokine receptor 6 (CCR6) and chemokine (C-C motif) ligand 20 (CCL20)-induced EMT in gastric cancer remain incompletely understood.

Purpose of the Study:

  • To elucidate the role of CrkL in CCL20/CCR6-mediated EMT in gastric cancer.
  • To investigate the underlying molecular pathways involved in this process.

Main Methods:

  • Immunohistochemistry and immunoblotting were used to assess CCR6 and CrkL expression in 90 gastric cancer tissues and five cell lines.
  • Gastric cancer cells underwent small interfering RNA (siRNA) treatment and in vitro assays to evaluate functional impacts.

Main Results:

  • Aberrant expression of CCR6 and CrkL was observed in gastric cancer, correlating with poor prognosis, metastasis, and advanced stage.
  • CCL20 stimulation upregulated p-CrkL, p-Akt, and EMT markers (vimentin, N-cadherin, MMP2) in MGC803 cells, an effect abrogated by si-CrkL.
  • Knockdown of CrkL significantly reduced MGC803 cell migration and invasion.

Conclusions:

  • CrkL mediates CCL20/CCR6-induced EMT in gastric cancer predominantly via the Akt pathway, not the Erk1/2 pathway.
  • The CCL20/CCR6-CrkL-Akt-EMT pathway represents a potential therapeutic target for antagonizing gastric cancer progression.